Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells

Modern Pathology

Volumn 18, Issue 12, 2005, Pages 1535-1541

  Popnikolov, Nikolay K ^a,b   Cavone, Sharon M ^a   Schultz, Pauline M ^a   Garcia, Fernando U ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYOSIN HEAVY CHAIN; NEUROTROPHIN RECEPTOR; PARAFFIN; PROTEIN P63; PROTEIN P75;

ARTICLE; BENIGN TUMOR; BLOOD VESSEL; BREAST CARCINOMA; BREAST CELL; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST LESION; BREAST PAPILLOMA; BREAST TUMOR; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVALUATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; MYOEPITHELIUM CELL; NERVE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SCLEROSIS; TISSUE SECTION; TUMOR CELL;

ADENOCARCINOMA; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; EPITHELIAL CELLS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MUSCLE, SMOOTH; MYOSIN HEAVY CHAINS; PAPILLOMA, INTRADUCTAL; RECEPTOR, NERVE GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 27944486760     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800487     Document Type: Article

References (23)

1. Lazard D, Sastre X, Frid MG, et al. Expression of smooth muscle specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993;90:999-1003.
2. Wang NP, Wan BC, Skelly M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997;5:141-151.
3. Nagle RB, Bocker W, Davis JR, et al. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem 1986;34:869-881.
4. Joshi MG, Lee AK, Pedersen CA, et al. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 1996;9:57-62.
5. Egan MJ, Newman J, Crocker J, et al. Immunohistochemical localization of S-100 protein in benign and malignant conditions of the breast. Arch Pathol Lab Med 1987;111:28-31.
6. Raju UB, Lee MW, Zarbo RJ, et al. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 1989;2:569-573.
7. Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 2002;15:397-405.
8. Lele SM, Graves K, Gatalica Z. Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2000;8:32-36.
9. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060.
10. Reis-Filho JS, Schmidtt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280-289.
11. Huang EJ, Reichardt LF. Neutrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:667-736.
12. Sariola H. The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci 2001;58:1061-1066.
13. Thompson ST, Schatteman GC, Gown AM, et al. A monoclonal antibody against nerve growth factor receptor. Immunihistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol 1989;92:415-423.
14. Aragona M, Panetta S, Silipigni AM, et al. Nerve growth factor receptor immunohistochemistry in breast cancer patients. Cancer Invest 2001;19:6.
15. Sakamoto Y, Kitajima Y, Edakuni G, et al. Combined evaluation of NGF and p75NGFR expression is a biomarker for predicting prognosis in human invasive ductal breast carcinoma. Oncol Rep 2001;8:973-980.
16. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003;100:10393-10398.
17. Sorlie T, Tibshirani R, Parker J, et al. Repeated observations of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423.
18. Popnikolov NK, Ayala AG, Graves K, et al. Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas. Am J Clin Pathol 2003;120:161-167.
19. Stingl J, Eaves CJ, Kuusk U, et al. Phenotypic and functional characterization in vitro of a multipotent breast epithelial cell present in the normal adult human breast. Differentiation 1998;63:201-213.
20. Pechoux C, Gugjonsson T, Ronnov-Jessen L, et al. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 1999;206:88-99.
21. Guate JL, Fernandez N, Lanzas JM, et al. Expression of p75NTR and Trk neutrophin receptors in normal and neoplastic human prostate. Br J Urol Int 1999;84:495-502.
22. Liang Y, Marcusson JA, Johansson O. Light and electron microscopic immunohistochemical observation of p75 nerve growth factor receptor- immunoreactive dermal nerves in prurigo nodularis. Arch Dermatol Res 1999;291:14-21.
23. Chesa PG, Retting WL, Thompson TM, et al. Immunohistochemical analysis of nerve growth factor receptor expression in normal; and malignant human tissues. J Histochem Cytochem 1998;36:383-389.